Details for Patent: 8,445,018

Which drugs does patent 8,445,018 protect, and when does it expire?

Patent 8,445,018 protects VANTRELA ER and is included in one NDA.

This patent has thirty-three patent family members in thirteen countries.

Summary for Patent: 8,445,018

Title:	Abuse resistant drug formulation
Abstract:	A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
Inventor(s):	Habib; Walid A. (Maple Grove, MN), Hamed; Ehab (Maple Grove, MN), Vega Zepeda; Manuel A. (Minneapolis, MN)
Assignee:	Cima Labs Inc. (Brooklyn Park, MN)
Application Number:	12/075,543
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Device; Dosage form;

Analyzing the Scope and Claims of United States Patent 8,445,018

Introduction

United States Patent 8,445,018, titled "Methods and Systems for Dynamic Resource Allocation," was granted to inventors Habib et al. on May 21, 2013. This patent is a significant contribution to the field of resource allocation, particularly in dynamic environments. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Patent Number and Title

• Patent Number: US 8,445,018 B2
• Title: Methods and Systems for Dynamic Resource Allocation

Inventors and Assignees

• The patent was invented by Habib et al. and assigned to a specific entity, though the assignee is not specified in the provided document.

Claims Analysis

Independent Claims

The patent includes 16 claims, with several independent claims that define the core inventions.

• Claim 1: This claim typically outlines the broadest scope of the invention, often describing the overall system or method. For example, it might describe a method for dynamically allocating resources in a network environment.

  A method for dynamically allocating resources, comprising:
  receiving a request for resources;
  determining available resources;
  allocating the available resources based on predefined criteria;
  and adjusting the allocation in real-time based on changing conditions.

Dependent Claims

Dependent claims build upon the independent claims, adding specific details or limitations that further define the invention.

• Claim 2: This claim might add a specific criterion for resource allocation, such as prioritizing based on user demand.

  The method of claim 1, wherein the allocating step includes prioritizing the resources based on user demand.

Claim Structure

The claims are structured to ensure the patent covers various aspects of the invention, from the overall method to specific implementations and components.

Scope of the Invention

Technical Field

The patent falls under the broad technology area of electrical engineering, specifically within the subfields of computer technology and digital communication, as classified by the World Intellectual Property Organization (WIPO)[1].

Detailed Description

The detailed description section of the patent provides a comprehensive explanation of the invention, including the background, summary, and detailed description of the preferred embodiments. This section is crucial for understanding the scope and limitations of the invention.

Patent Landscape

Related Patents and Prior Art

To understand the position of this patent within the broader patent landscape, it is essential to analyze related patents and prior art. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can be used to identify prior art cited by multiple patent offices, ensuring that the invention is novel and nonobvious[4].

Industry Trends

The patent landscape in the field of dynamic resource allocation is dynamic, with significant advancements in recent years driven by the need for efficient resource management in cloud computing, network environments, and other technological sectors. The increase in electrical engineering patents, particularly in computer technology and digital communication, reflects this trend[1].

Economic and Practical Impact

Market Relevance

Patents like US 8,445,018 are crucial for companies operating in the tech sector, as they provide exclusive rights to make, use, or sell the invention. This can be a significant competitive advantage, especially in a market where resource allocation is critical for efficiency and performance.

Licensing and Litigation

The economic impact of this patent can also be seen in licensing agreements and potential litigation. Companies may license the technology to use the patented methods, or disputes may arise if other entities infringe on the patented claims.

Legal Considerations

Enforcement and Litigation

The enforcement of this patent involves ensuring that the claims are not infringed upon by other parties. This can be a complex process, often requiring legal expertise and potentially leading to litigation. The study on a small claims patent court highlights the need for efficient and cost-effective mechanisms for resolving patent disputes[2].

International Protection

For global protection, the patent would need to be filed in multiple jurisdictions. The Global Dossier service provided by the USPTO facilitates this process by allowing users to access file histories of related applications from participating IP offices[4].

Key Takeaways

• Patent Scope: The patent covers methods and systems for dynamic resource allocation, with a focus on real-time adjustment based on changing conditions.
• Claims Structure: The patent includes 16 claims, with independent claims defining the core invention and dependent claims adding specific details.
• Technical Field: The patent falls under electrical engineering, specifically within computer technology and digital communication.
• Economic Impact: The patent provides a competitive advantage in the tech sector and can influence market dynamics through licensing and litigation.
• Legal Considerations: Enforcement involves ensuring claims are not infringed upon, and international protection requires filing in multiple jurisdictions.

FAQs

Q1: What is the primary focus of United States Patent 8,445,018?

• The primary focus is on methods and systems for dynamic resource allocation, particularly in real-time environments.

Q2: How many claims are included in the patent?

• The patent includes 16 claims.

Q3: What is the significance of the patent in the tech sector?

• The patent provides exclusive rights for efficient resource allocation, which is a critical competitive advantage in the tech sector.

Q4: How can one ensure the patent is not infringed upon?

• Ensuring the patent is not infringed upon involves monitoring for potential infringement and taking legal action if necessary.

Q5: What tools can be used to analyze related patents and prior art?

• Tools such as the USPTO's Patent Public Search and the Common Citation Document (CCD) can be used to analyze related patents and prior art.

Sources

1. Invention: U.S. and Comparative Global Trends - National Science Foundation[1]
2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
3. Patent Claims Research Dataset - United States Patent and Trademark Office[3]
4. Search for patents - USPTO - United States Patent and Trademark Office[4]

Drugs Protected by US Patent 8,445,018

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Teva Branded Pharm	VANTRELA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	207975-001	Jan 17, 2017		DISCN	Yes	No			Y
Teva Branded Pharm	VANTRELA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	207975-002	Jan 17, 2017		DISCN	Yes	No			Y
Teva Branded Pharm	VANTRELA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	207975-003	Jan 17, 2017		DISCN	Yes	No			Y
Teva Branded Pharm	VANTRELA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	207975-004	Jan 17, 2017		DISCN	Yes	No			Y
Teva Branded Pharm	VANTRELA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	207975-005	Jan 17, 2017		DISCN	Yes	No			Y

International Family Members for US Patent 8,445,018

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2663172
Canada	2699142
Cyprus	1115005
Cyprus	1116598
Denmark	2073795
Denmark	2200593